First-line pembrolizumab in patients with advanced non-small cell lung cancer and high PD-L1 expression: real-world data from a Spanish multicenter study.
Piedra A, Martínez-Recio S, Hernández A, Morán T, Arriola E, Recuero-Borau J, Cobo M, Cordeiro P, Mosquera J, Fernández M, García-Campelo R, Calles A, Álvarez R, Zapata-García M, Isla D, Callejo A, Iranzo P, Serra-López J, Barba A, Sullivan I, Felip E, Majem M.
Piedra A, et al. Among authors: alvarez r.
Front Oncol. 2024 Dec 17;14:1510278. doi: 10.3389/fonc.2024.1510278. eCollection 2024.
Front Oncol. 2024.
PMID: 39741981
Free PMC article.